SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-147547
Filing Date
2022-05-11
Accepted
2022-05-11 16:25:03
Documents
15
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329066d8k.htm   iXBRL 8-K 26177
2 EX-99.1 d329066dex991.htm EX-99.1 67107
3 EX-99.2 d329066dex992.htm EX-99.2 35904
7 GRAPHIC g329066page005.jpg GRAPHIC 3152
  Complete submission text file 0001193125-22-147547.txt   273984

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220505.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220505_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220505_pre.xml EX-101.PRE 10824
9 EXTRACTED XBRL INSTANCE DOCUMENT d329066d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 22914134
SIC: 3841 Surgical & Medical Instruments & Apparatus